Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 69367-288

Reonly bupropion HCL extended-release tablets are a prescription medication used for the treatment of depression, seasonal affective disorder (SAD), and to help quit smoking. Each tablet contains 150mg of Bupropion Hydrochloride, USP, and should be taken once a day as directed by a physician. Patients are advised not to take these tablets in combination with Zyban or other medications containing bupropion hydrochloride. This medication should be stored at 20-25°C and dispensed in a tightly sealed container. A medication guide is provided separately to each patient by the pharmacist. These tablets are manufactured by CSPC Ouyi Pharmaceutical Co., Ltd., Shijiazhuang, Hebei, China, and distributed by Westminster Pharmaceuticals, LLC, Nashville, TN 37217.*

This is a medication label for Reonly, a brand of buPROPion HCL extended-release tablets. The tablets come in a bottle of 90 and each tablet contains 300mg of Bupropion Hydrochloride. They are for once daily use or as directed by a physician. The label contains a warning to not use in combination with Zyban or any other medicine that contains bupropion hydrochloride. It also provides information on how to store and dispense the medication, as well as the manufacturer and distributor information. The label mentions a trademark for Zyban® owned by GlaxoSmithKline LLC.*